The historical rank and industry rank for Halozyme Therapeutics's Days Sales Outstanding or its related term are showing as below:
HALO'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 21.8 Med: 69.75 Max: 107.19
Current: 93.59
During the past 13 years, Halozyme Therapeutics's highest Days Sales Outstanding was 107.19. The lowest was 21.80. And the median was 69.75.
HALO's Days Sales Outstanding is ranked worse than 62.65% of 889
companies
in the Biotechnology industry
Industry Median: 71.97
vs HALO: 93.59
Halozyme Therapeutics's Days Sales Outstanding
increased
from Dec. 2022 (86.20) to Dec. 2023 (89.88).
Halozyme Therapeutics Days Sales Outstanding Historical Data
The historical data trend for Halozyme Therapeutics's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Halozyme Therapeutics Days Sales Outstanding Chart
Competitive Comparison of Halozyme Therapeutics's Days Sales Outstanding
For the Biotechnology subindustry, Halozyme Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Halozyme Therapeutics's Days Sales Outstanding Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Halozyme Therapeutics's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Halozyme Therapeutics's Days Sales Outstanding falls into.
Halozyme Therapeutics Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Halozyme Therapeutics (NAS:HALO) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Halozyme Therapeutics Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Halozyme Therapeutics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Halozyme Therapeutics (Halozyme Therapeutics) Business Description
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HALO has been successfully added to your 